VeriMomIst hypericum perforatum phytoplacenta culture extract in der Schwangerschaft sicher?
No harmonised CLP reproductive classification (ECHA Annex VI) or CIR/SCCS safety opinion specifically flagging 'Hypericum perforatum phytoplacenta culture extract' as a reproductive hazard; published literature on Hypericum shows pharmacological/systemic effects when taken orally but no confirmed teratogenicity that would trigger H360/H361 classification. Topical cosmetic use is expected to give low but measurable systemic exposure in adults (so exposure score 1). Sources considered: ECHA Annex VI (no harmonised classification for this ingredient), CIR (no specific adverse reproductive finding for cosmetic extracts of Hypericum), PubMed literature on Hypericum pharmacology.
Related ingredients
Frequently asked questions
- Ist hypericum perforatum phytoplacenta culture extract in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (ECHA Annex VI) or CIR/SCCS safety opinion specifically flagging 'Hypericum perforatum phytoplacenta culture extract' as a reproductive hazard; published literature on Hypericum shows pharmacological/systemic effects when taken orally but no confirmed teratogenicity that would trigger H360/H361 classification. Topical cosmetic use is expected to give low but measurable systemic exposure in adults (so exposure score 1). Sources considered: ECHA Annex VI (no harmonised classification for this ingredient), CIR (no specific adverse reproductive finding for cosmetic extracts of Hypericum), PubMed literature on Hypericum pharmacology.
- Ist hypericum perforatum phytoplacenta culture extract während des Stillens sicher?
- No authoritative safety assessment (CIR/SCCS/ECHA harmonised CLP) identifies this ingredient as a lactation/milk transfer reproductive hazard. Systemic absorption from topical use is expected to be low but not zero, so maternal exposure and potential minimal transfer to milk are possible but not demonstrated for this extract. Sources: PubMed literature on Hypericum systemic use (shows oral systemic effects rather than topical), CosIng/ECHA (no lactation-specific classification).
- Ist hypericum perforatum phytoplacenta culture extract sicher für Babyhaut?
- No evidence of infant-specific reproductive or developmental toxicity for this ingredient in authoritative sources; therefore hazard and mechanism scores default to 0. Because infant skin has higher absorption and surface-area-to-weight ratio, exposure score is increased by +1 relative to adult topical use (adult e=1 → infant e=2). Note: photosensitizing constituents of Hypericum (hypericin) could be relevant for topical use on infants, but reproductive/endocrine effects in infants are not documented. Sources: general Hypericum literature (PubMed), CosIng/ECHA (no infant-specific safety findings).
- Wie bewertet VeriMom hypericum perforatum phytoplacenta culture extract?
- VeriMom bewertet hypericum perforatum phytoplacenta culture extract mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu hypericum perforatum phytoplacenta culture extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu hypericum perforatum phytoplacenta culture extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.